BioSpace News Archive

Business

Nortech Systems Reports Third Quarter 2023 Results

Nortech Systems Incorporated, a leading provider of engineering and manufacturing solutions for complex electromedical and electromechanical products serving the medical, industrial and defense markets, reported 2023 third quarter results for the period ended September 30, 2023.

November 8, 2023
·
12 min read
Business

Nephros Announces Results for Quarter Ended September 30, 2023

Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the third quarter ended September 30, 2023.

November 8, 2023
·
11 min read
Business

Vapotherm Reports Third Quarter 2023 Financial Results

Vapotherm, Inc., announced third quarter 2023 financial results and related highlights.

November 8, 2023
·
23 min read
Business

Orthofix Reports Third Quarter 2023 Results

Orthofix Medical Inc. reported its financial results for the quarter ended September 30, 2023.

November 8, 2023
·
16 min read
Business

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2023

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) (“Amphastar” or the “Company”) today reported results for the three months ended September 30, 2023.

November 8, 2023
·
16 min read
Pharm Country

IO Biotech Announces Participation in Upcoming November 2023 Investor Conferences

IO Biotech, a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on its T-win® technology platform, announced its participation in the upcoming investor conferences.

November 8, 2023
·
3 min read
Business

Alimera Appoints Maggie A. Pax to Its Board of Directors

Alimera Sciences, Inc., a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announces the addition of Maggie A. Pax to its Board of Directors.

November 8, 2023
·
3 min read
Lone Star Bio

Real-World Evidence Confirms IDgenetix®-Guided Medication Management Significantly Improves Response and Remission Rates in Patients with Major Depressive Disorder

Castle Biosciences, Inc. announced data from a single-site, open-label study demonstrating the consistent impact of IDgenetix® on medication response and remission rates in patients with major depressive disorder.

November 8, 2023
·
7 min read
Business

23andMe Reports Second Quarter Fiscal 2024 Financial Results

23andMe Holding Co., a leading human genetics and biopharmaceutical company, reported its financial results for the second quarter of fiscal year 2024, which ended September 30, 2023.

November 8, 2023
·
19 min read
Business

89bio Reports Third Quarter 2023 Financial Results and Provides Corporate Updates

89bio, Inc. reported its financial results for the third quarter ended September 30, 2023.

November 8, 2023
·
7 min read